“I feel very privileged to have the opportunity to care for and treat patients with vision threatening diseases. I believe the doctor-patient relationship to be special, and therefore I strive to treat every patient as if they are a family member. That’s why I prioritize listening to and understanding my patients, which I believe leads to the best care.”
Fellowship
Vitreoretinal Surgery
Casey Eye Institute, Oregon Health & Science University
Portland, Oregon
Uveitis and Clinical Ocular Immunology
Casey Eye Institute, Oregon Health & Science University
Portland, Oregon
Clinical Uveitis
Devers Eye Institute
Portland, Oregon
Residency
Ophthalmology
Moran Eye Center, University of Utah
Salt Lake City, Utah
Internship
University of Utah
Salt Lake City, Utah
Medical/Graduate School
SUNY Upstate Medical University
Syracuse, New York
- American Academy of Ophthalmology
- The Association for Research in Vision and Ophthalmology
- American Society of Retina Specialists
- American Uveitis Society
- Principal Investigator, MEERKAT — Phase III Study to Evaluate the Efficacy of Intravitreal Anti-IL6 Biologic Therapy in Patients with Uveitis Macular Edema
- Principal Investigator, TYNI — Phase III Study to Evaluate the Efficacy of Two YUTIQ for the Treatment of Chronic Non-infectious Intraocular Inflammation
- Sub-investigator, Kodiak KSI-CL-102 — Phase II, Prospective, Double-masked, Randomized, Active Comparator-controlled, Multicenter Study to Investigate the Efficacy and Safety of Repeated Intravitreal Administration of KSI-301 in Subjects with Neovascular (wet) Age-related Macular Degeneration.
- Sub-investigator, Beacon KS301P103 — A 12-month, 2-arm, Randomized, Double-masked, Multicenter Phase III Study Assessing the Efficacy and Safety of KSI-301 q 8w versus Aflibercept q 4 in Adult Patients with Visual Impairment due to Retinal Vein Occlusive Disorders
- Sub-investigator, Glimmer KS301P105 — A 24-month, 2-Arm, Randomized, Double-masked, Multicenter Phase III Study Assessing the Efficacy and Safety of KSI-301 Individualized Q 24w-flex Regimen versus Aflibercept q 4w in Adult Patients with Visual Impairment due to Treatment Naive Diabetic Macular Edema
- Sub-investigator, Daylight KS301P107 — A 12-Month, 2-Arm, Randomized, Double-masked, Multicenter Phase III Study Assessing the Efficacy and Safety of KSI-301 q 4w versus Aflibercept q 8 in Adult Patients with Visual Impairment due to Neovascular (Wet) Age-related Macular Degeneration
- Sub-investigator, Glow KS301P106 — A 24-month, 2-arm, Sham-controlled, Double-masked, Multicenter Phase III Study Assessing the Efficacy and Safety of KSI-301 5 mg versus Those Dosed with Sham
- Sub-investigator, Tarsier TRS4Vision — A Phase III, Randomized, Active-controlled, Double-masked Study to Evaluate the Safety and Efficacy of TRS01 Eye Drops in the Treatment of Subjects with Active Non-infectious Anterior Uveitis, Including Subjects with Uveitis Glaucoma
- Sub-investigator, Telescope — GTTELESCOPE — A Study to Genetically Define Subjects with Geographic Atrophy Secondary to Age-related Macular Degeneration
- Primary Investigator, Acelyrin — A Phase IIb Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior-, or Pan-uveitis
- Patel KG, Hilton T, Choi RY, Abbey AM. Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine. Ocular Immunology and Inflammation. July 2022.
- Choi RY. Noninfectious Uveitis in Pregnancy. Retina Specialist. 2021.
- Walters AR, Choi RY, Flaxel CJ. Multiple Evanescent White Dot Syndrome Presenting in a Patient With Punctate Inner Choroidopathy. Journal of VitreoRetinal Diseases. November 3, 2020.
- Simonett JM, Choi RY, Flaxel CJ. Filtering-associated Endophthalmitis Following Trabeculectomy or Tube-shunt Implant. Ophthalmology Retina. Epub ahead of print, 2020.
- Choi RY, Brown JM, Kalpathy-Cramer J, Chan RP, Ostmo S, Chiang MF, Campbell JP. Real World Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale. Ophthalmology Retina. Epub ahead of print, 2020.
- Choi RY, Coyner AS, Kalpathy-Cramer J, Chiang MF, Campbell JP. Introduction to Machine Learning, Neural Networks, and Deep Learning. Translational Vision Science & Technology. 2020 9(2):14.
- Choi RY, Flaxel C, Strnad L, Lauer AK, Suhler E. A First Case of Gordonia Bronchialis Associated Endophthalmitis. Emerging Infectious Diseases. 2019 25(5), 1017-1019.
- Choi RY, Lin P. Focal Points: Diagnosis and Management of Anterior Uveitis. American Academy of Ophthalmology. February 2019.
- Choi RY, Rivera E, Rosenbaum JT. Reclassifying Idiopathic Uveitis: Lessons from a Tertiary Uveitis Center. American Journal of Ophthalmology. 2019 198, 193-199.
- Choi RY, Jacoby R, Shakoor A. Multi-Modality Ocular Imaging in a Case of Hyperviscosity Syndrome Associated with Lymphoplasmacytic Leukemia: The Images Tell the Story. Retinal Cases and Brief Reports. 2019 13(3):238-240.
- Choi RY, Brown JM, Kalpathy-Cramer J, Chan RP, Ostmo S, Campbell JP, Chiang MF. Analysis of the Imaging and Informatics Retinopathy of Prematurity (i-ROP) Vascular Severity Score in Patients with Treatment Requiring Retinopathy of Prematurity. The Retina Society, 2019. London, England.
- Choi RY, Brown JM, Kalpathy-Cramer J, Chan RP, Ostmo S, Campbell JP, Chiang MF. Analysis of the Imaging and Informatics Retinopathy of Prematurity (i-ROP) Vascular Severity Score in Patients with Treatment Requiring Retinopathy of Prematurity. The Association for Research in Vision and Ophthalmology Conference, 2019. Vancouver, BC.
- Choi RY, Flaxel C. A Patient with Ties to Christopher Columbus, Al Capone, and Leo Tolstoy. Macula Society Annual Meeting, 2019. Bonita Springs, FL.
- Choi RY, Flaxel C. Caldonia! Oh wait, no…Gordonia… A Curious Case of Endophthalmitis. Retina Society Annual Meeting, 2018. San Francisco, CA.
- Choi RY, Li Y, Siak J, Lu C, Lee B, Yang J, Liu G, Suhler E, Lin P, Fujimoto J, Rosenbaum J, Huang D. Evaluation of Vitreous Cells Using Swept-Source OCT. The Association for Research in Vision and Ophthalmology Conference, 2018. Honolulu, HI.
- Choi RY, Rivera E, Rosenbaum JT. Reclassifying Idiopathic Uveitis: Lessons from a Tertiary Uveitis Center. American Uveitis Society Winter Symposium, 2018. Park City, UT.
- Choi RY, Farnsworth K, Gorusupudi A, Bernstein PS. A Clinical Trial of Fish Oil Supplementation in Patients with Autosomal Dominant Stargardt Macular Dystrophy. The Association for Research in Vision and Ophthalmology Conference, 2016. Seattle, WA.
- Choi RY, Sharifzadeh M, Gellerman W, Gorusupudi A, Bernstein PS. Foveal Sparkles. Macula Society Annual Meeting, 2016. Miami, FL.
- Choi RY, Farnsworth K, Gorusupudi A, Bernstein PS. Long-term Follow-up of Autosomal Dominant Stargardt Macular Dystrophy (STGD3) Subjects Enrolled in a Fish Oil Supplement Interventional Trial. Macula Society Annual Meeting, 2016. Miami, FL.
- Super Doctors “Texas Rising Star Award”, 2022, 2023 and 2024
- Reviewer for American Journal of Ophthalmology Case Reports Journal
- Reviewer for Retina, Retinal Cases and Brief Reports Journal
- Fellow of the Year Award, Casey Eye Institute, 2019
- Jack McGovern Coats’ Disease Foundation Travel Award, 2019
- Heed Ophthalmic Foundation Fellowship Grant Recipient, 2019
- Retina Research Foundation Joseph M. and Eula C. Lawrence Travel Grant, Association for Research in Vision and Ophthalmology, 2019
- American Uveitis Society Fellow Travel Award, 2018